PANMOLECULARBIONET SL
Company details
- Active NIF/CIF: B84864339
-
Telephone: Not available
-
Date of last BORME entry: 14/01/2009
-
Sector: Human Health and Social Work Activities
-
Address: Calle Camino Nuevo, 40, 28792 Miraflores de la Sierra, Madrid, España See in map
-
Website: Not available
-
Featured products:
More information on PANMOLECULARBIONET SL
-
14/01/2009 | BORME act no.: 19104 | Register: MADRIDModificaciones estatutarias -
14/01/2009 | BORME act no.: 19104 | Register: MADRIDAmpliacion del objeto social
-
07/01/2009 | BORME act no.: 3712 | Register: MADRIDDepósito de cuentas anuales (Diciembre de 2008)
-
05/01/2009 | BORME act no.: 3103 | Register: MADRIDDepósito de cuentas anuales (Diciembre de 2008)
-
21/11/2006 | BORME act no.: 555672 | Register: MADRIDConstitución
-
21/11/2006 | BORME act no.: 555672 | Register: MADRIDNombramientos
Other information
The CIF of PANMOLECULARBIONET SL is B84864339, and its status in the business field is active. The company's economic activity is classified under CNAE 8690 - Other health activities. Additionally, its SIC code - also identifies it. PANMOLECULARBIONET SL has a team of Between 10 and 49 employees and records an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Madrid, with a total of 1 executive positions. The last announcement in Borme was published on 14/01/2009, and its last submission of ordinary annual accounts corresponds to the year -. To obtain contact information for PANMOLECULARBIONET SL, such as phone number, address, or website, you can visit the Company Data module. If you wish to obtain more information about PANMOLECULARBIONET SL, you can review some of our available financial reports, the company's Annual Accounts, or check its default incidents in the RAI delinquency file. The financial, business, and legal information provided for PANMOLECULARBIONET SL comes from official sources and is up to date as of today.
Do you want to know more about PANMOLECULARBIONET SL??
Find out more about this company by consulting these reports:
